NASDAQ: SBFM
Sunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?

Insider buying vs selling

Have Sunshine Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SBFM insiders and whales buy or sell their stock.

SBFM Shareholders

What type of owners hold Sunshine Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Malek Chamoun75.42%3,700,000$4.00MInsider
Camille Sebaaly3.56%174,465$188.42kInsider
Steve N. Slilaty2.65%130,000$140.40kInsider
David Natan2.04%100,000$108.00kInsider
Citadel Advisors LLC1.10%53,929$58.24kInstitution
Virtu Financial LLC0.48%23,388$25.26kInstitution
Xtx Topco Ltd0.33%16,156$17.45kInstitution
Morgan Stanley0.30%14,634$15.80kInstitution
Sbi Securities Co Ltd0.10%4,848$5.24kInstitution
Ubs Group Ag0.04%1,873$2.02kInstitution

1 of 2

SBFM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SBFM2.34%83.66%
GELS0.80%13.96%
SHPH1.21%98.79%
BGM3.25%0.00%
SNOA2.76%97.24%

Sunshine Biopharma Stock Ownership FAQ

Who owns Sunshine Biopharma?

Sunshine Biopharma (NASDAQ: SBFM) is owned by 2.34% institutional shareholders, 83.66% Sunshine Biopharma insiders, and 13.99% retail investors. Malek Chamoun is the largest individual Sunshine Biopharma shareholder, owning 3.70M shares representing 75.42% of the company. Malek Chamoun's Sunshine Biopharma shares are currently valued at $4.00M.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.